Condition: Shoulder Tendinopathy · Metabolic Alterations · Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Given the close correlation reported in the literature between onset and progression of tendon pathology in subjects affected by the alteration of metabolic disorders such as obesity, diabetes mellitus and lipidic metabolic alterations, with the present study the association between the nutritional state, metabolic profile and clinical outcome of patients following treatment with blood-derived orthobiological for shoulder tendinopathies will be evaluated. The primary aim of this study is to identify the proportion of tendinopatic patients responsive and non-responsive to treatment with "Platelet rich growth factors" PRGF at six months follow up and the correlation with their nutritional status.
This description comes directly from the study's public registry record.
Paola De Luca, PhD · +39 3921385179 · deluca.paola@grupposandonato.it
Michela Taiana, PhD · +39 3335952857 · michelamaria.taiana@grupposandonato.it
Always discuss trial participation with your own doctor first.
| I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | Milan, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06536582